The assessment of effect of commercial chlorhexidine and conventional tooth flosses on gingivitis reduction: Randomized clinical trial
- Conditions
- gingivitis.Gingivitis and periodontal diseases
- Registration Number
- IRCT20210305050584N1
- Lead Sponsor
- Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 51
Lack of systemic disease
Existence of bleeding on probing (BOP) in at least one dental space in each quadrant (one quarter of the jaw)
Maximum pocket depth is 2 mm and no gingival recession
Gingival index loe & sillness more than 1.5
At least 5 teeth per quadrant
Maximum interdental space is 1 mm
smoking
Use of any type of dental prosthesis appliance, orthodontics, cavities or any plaque blocking agent other than calculus
Use of systemic antibiotics in the last 3 months before the start of the study
Use of drugs that affect the condition of the gums.
Chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs)
Consumption of mouthwash in the last 6 months
Systemic diseases that cause changes in periodontal health, such as diabetes, hormonal problems, patients at risk for endocarditis, pregnant women and nursing mothers.
Existence of oral diseases other than gingivitis
parafunctional habits
malocclusion
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gingival index. Timepoint: Baseline and 2,4,8 weeks after intervention. Method of measurement: Löe&Sillness gingival index.;Bleeding on probing index. Timepoint: Baseline and 2,4,8 weeks after intervention. Method of measurement: Ainamo&Bay bleeding on probing index.;Plaque index. Timepoint: Baseline and 2,4,8 weeks after intervention. Method of measurement: Turesky modified Quigley-hein index.
- Secondary Outcome Measures
Name Time Method